Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds.
Inducible nitric oxide synthase (iNOS) is expressed during cutaneous wound repair. Mounting evidence suggests that wound nitric oxide (NO) augments collagen accumulation. We hypothesized that in vivo transfection of wound cells with the iNOS gene would increase physiological wound NO levels and thus augment collagen accumulation. Polyvinyl alcohol sponges were instilled with a mammalian expression plasmid (pMP6) containing either the chloramphenicol acetyl transferase (CAT) reporter or murine iNOS gene driven by a CMV immediate-early promoter. Plasmid DNA was injected alone or in complex with cationic liposomes, and the sponges were placed subcutaneously in male Sprague-Dawley rats which had received a longitudinal dorsal midline incision. Animals were sacrificed at different time points post-wounding and the sponges assayed for CAT activity, transfected iNOS mRNA, total nitrate and nitrite concentration (NOx) (as an index of wound NO synthesis), and hydroxyproline content (as an index of sponge collagen accumulation). The results demonstrate that wound cells were more efficiently transfected by naked DNA than by liposome mediated transfection and that maximal expression of both iNOS and CAT occurred at 48 hrs with a rapid decline after this time point. After 7 days, iNOS transfected sponges had accumulated significantly more collagen than those transfected with CAT. We conclude that cutaneous wounds can be successfully transfected by direct injection of naked DNA and that increased iNOS expression precedes an increase in collagen synthesis.
Thornton
F J
FJ
Department of Surgery, Sinai Hospital of Baltimore, Maryland 21215, USA.
Schäffer
M R
MR
Witte
M B
MB
Moldawer
L L
LL
MacKay
S L
SL
Abouhamze
A
A
Tannahill
C L
CL
Barbul
A
A
D000818:Animals; D003094:Collagen / Q000096:biosynthesis*; D004247:DNA; D004337:Drug Carriers; D015316:Genetic Therapy / Q000379:methods; D008081:Liposomes; D008297:Male; D019001:Nitric Oxide Synthase / Q000096:biosynthesis* / Q000235:genetics; D052247:Nitric Oxide Synthase Type II; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000293:injuries*; D014162:Transfection; D014950:Wounds, Penetrating / Q000378:metabolism* / Q000628:therapy
D004337:Drug Carriers; D008081:Liposomes; D003094:Collagen; D004247:DNA; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat